North America Organ Preservation Solutions Market Drivers and Forecasts by 2028

The organ preservation solutions market in North America is expected to grow from US$ 102.86 million in 2021 to US$ 162.88 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.

The US, Canada, and Mexico are major economies in North America. Growing demand for organ transplantation is the major factor driving the growth of the North America organ preservation solutions market. Organ transplantation is a surgical procedure used when a patient's organ no longer functions properly. Organ transplantation is most for heart, liver, and kidney. However, the rising prevalence of chronic diseases is necessitating organ transplantation for organs such as the lung, pancreas, cornea, and vascular tissues. Organ transplantation is regarded as one of the most significant advances in modern medicine. Rise in chronic diseases that cause damage to the functions of the heart, lung, liver, kidney, and other organs is leading to an increase in the number of organ transplants. Moreover, excessive alcohol consumption leads to liver cirrhosis and ultimately needs liver transplant and a poor diet contribute to the development of renal and hepatic illnesses, which can lead to organ failure. This is yet another factor contributing to the growth of the organ transplantation and therefore preservation solutions market. Transplantation surgeries are becoming more common. The developed countries have seen an increase in the number of organ transplant surgeries. According to the National Chronic Kidney Disease Fact Sheet 2017 (US), approximately 30 million people in the US are estimated to have chronic kidney disease. Similarly, the National Institute of Diabetes and Digestive and Kidney Diseases reported that in 2017 nearly 661,000 Americans have kidney failure, with 468,000 undergoing dialyses and approximately 193,000 undergoing kidney transplantations. As a result, the rising incidence of chronic kidney diseases is likely to increase the demand for kidney transplantation in the coming years, which boosts the need for solutions to keep the organs in a healthy condition. Similarly, it is expected that the rising cases of heart diseases will drive the market in the coming years.

In North America, the COVID-19 pandemic has had a significant impact on the US. The country has recorded the highest number of cases in the region. Various healthcare research centers across the country were solely focused on COVID 19 treatments. Due to the scarcity of physicians in the area, the focus of healthcare facilities has shifted from organ transplantation and other surgeries to the COVID-19 management. On the other hand, COVID-19 causes complications in individual solid organ transplant candidates and recipients, as well as in the organ transplantation procedures. Based on the detection of viral RNA in organs that can be transplanted (e.g., lung, heart, kidney, intestine), there is a theoretical risk of transmitting SARS-CoV-2 (the virus that causes COVID-19) from an organ donor to a recipient; however, only a single donor-derived infection from a lung recipient has been reported in the US to date. As solid organ transplant recipients are immunocompromised, they may be at a greater risk of contracting COVID-19 after transplantation, although this link has not been explored. In addition, various recommendations have been noted in the vaccination plan of organ transplantation patients. These instructions are in line with the advice and guidance of the International Society for Heart and Lung Transplantation (ISHLT); the American Society of Transplantation (AST) also recommends vaccination at least two weeks prior to transplantation. COVID-19-related issues have hampered organ transplantation in the region, posing a threat to the organ preservation solution market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America organ preservation solutions market. The North America organ preservation solutions market is expected to grow at a good CAGR during the forecast period.

North America Organ Preservation Solutions Market Segmentation

 

North America Organ Preservation Solutions Market – By Solution

• University of Wisconsin Solution (UW)
• Custodiol HTK
• Perfadex
• Others

North America Organ Preservation Solutions Market – By Technique

• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Others

North America Organ Preservation Solutions Market – By Organ Type

• Kidneys
• Liver
• Lungs
• Heart
• Others

North America Organ Preservation Solutions Market, by Country

• US
• Canada
• Mexico

North America Organ Preservation Solutions Market - Companies Mentioned

• 21ST CENTURY MEDICINE
• Accord Healthcare
• Bridge to Life Ltd
• Dr. Franz Koehler Chemie GmbH
• OrganOx Limited
• Paragonix Technologies, Inc
• TransMedics
• Waters Medical Systems LLC
• XVIVO Perfusion

North America Organ Preservation Solutions Report Scope